Catheter Precision, Inc. (VTAK): Cash & Equivalents
$88.0K
As of 2025-12-31
$643.0K
As of 2026-06-30
-82.3%
3-year compound annual growth
-67.4%
5-year compound annual growth
| Period ended | Cash & Equivalents | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $88.0K | -96.9% | 2026-03-31, Balance as of period end |
| 2024-12-31 | $2.87M | -19.4% | 2026-03-31, Balance as of period end |
| 2023-12-31 | $3.56M | -77.5% | 2025-03-31, Balance as of period end |
| 2022-12-31 | $15.86M | +5.4% | 2023-03-28, Balance as of period end |
| 2021-12-31 | $15.04M | -37.1% | 2023-03-28, Balance as of period end |
| 2020-12-31 | $23.91M | +63.9% | 2022-03-24, Balance as of period end |
| 2019-12-31 | $14.58M | -77.3% | 2021-03-17, Balance as of period end |
| 2018-12-31 | $64.31M | +680.8% | 2020-03-11, Balance as of period end |
| 2017-12-31 | $8.24M | n/a | 2019-03-15, Balance as of period end |
Cash & Equivalents at similar companies
| Company | Year ended | Cash & Equivalents | Change YoY |
|---|---|---|---|
| Catheter Precision, Inc. (VTAK) | 2025-12-31 | $88.0K | -96.9% |
| Harvard Apparatus Regenerative Technology, Inc. (HRGN) | 2025-12-31 | $1.35M | -45.6% |
| Sintx Technologies, Inc. (SINT) | 2025-12-31 | $4.14M | +15.1% |
| Co-Diagnostics, Inc. (CODX) | 2025-12-31 | $11.88M | +304.7% |
| RenovoRx, Inc. (RNXT) | 2025-12-31 | $7.02M | -1.8% |
| EBR Systems, Inc. (NONE.) | 2025-12-31 | $5.79M | -16.2% |
| Vycor Medical Inc (VYCO) | 2025-12-31 | $87.0K | -17.7% |
| Pulse Biosciences, Inc. (PLSE) | 2025-12-31 | $80.73M | -31.6% |
| Femasys Inc (FEMY) | 2025-12-31 | $9.27M | +168.5% |
Compare VTAK, HRGN, SINT, CODX side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗